drugset / Trial / NCT01382654
Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis
RandomizedCrossoverQuadruple-blindTreatment
Summary
The objectives of this study were to: * Examine the tolerability of two formulations and two dose concentrations of epinastine. * Select formulation(s) of epinastine for future studies by evaluating the individual sensory attribute scores of the Nasal Spray Evaluation Questionnaire (NSEQ) collected after each study drug administration and the subject preference ranking assessed at the completion of the study. * Compare the preference of two formulations and two dose concentrations of epinastine compared to azelastine following a single dose of each in a randomized, double-blind, two-cohort, three-period crossover design.
Timeline
- Start
- 2006-09
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azelastine | Small molecule | 0.1 % | Intranasal |
| Subject | Epinastine | Small molecule | 0.1 % | Intranasal |
| Subject | Epinastine | Small molecule | 0.2 % | Intranasal |